| Identification | Back Directory | [Name]
((R)-1-((S)-2-AMino-3-phenylpropanaMido)-3-Methylbutyl)boronic acid | [CAS]
948294-96-0 | [Synonyms]
Des-pyrazinecarboxaldehyde Bortezomib
((R)-1-((S)-2-AMino-3-phenylpropanaMido)-3-Methylbutyl)boronic acid
Boronic acid, B-[(1R)-1-[[(2S)-2-amino-1-oxo-3-phenylpropyl]amino]-3-methylbutyl]- | [Molecular Formula]
C14H23BN2O3 | [MDL Number]
MFCD26940313 | [MOL File]
948294-96-0.mol | [Molecular Weight]
278.15 |
| Hazard Information | Back Directory | [Uses]
((R)-1-((S)-2-Amino-3-phenylpropanamido)-3-methylbutyl)boronic Acid is a useful research compound. | [Uses]
Des-pyrazinecarboxaldehyde Bortezomib is the intermediate and impurity for Bortezomib (B675700), which is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway. |
|
|